|
[1]
|
Bluher, M. (2019) Obesity: Global Epidemiology and Pathogenesis. Nature Reviews Endocrinology, 15, 288-298.
[Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Shin, Y.W. and Kim, D.H. (2005) Antipruritic Effect of Ginse-noside Rb1 and Compound K in Scratching Behavior Mouse Models. Journal of Pharmacological Sciences, 99, 83-88. [Google Scholar] [CrossRef]
|
|
[3]
|
Joh, E.H., Lee, I.A., Jung, I.H., et al. (2011) Ginsenoside Rb1 and Its Metabolite Compound K Inhibit IRAK-1 Activation—The Key-Step of Inflammation. Biochemical Pharmacology, 82, 278-286.
[Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Kim, K., Park, M., Lee, Y.M., et al. (2014) Ginsenoside Metabolite Compound K Stimulates Glucagon-Like Peptide-1 Secretion in NCI-H716 Cells via Bile Acid Receptor Activation. Archives of Pharmacal Research, 37, 1193-1200.
[Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Kim, S., Kang, B.Y., Cho, S.Y., et al. (2004) Compound K In-duces Expression of Hyaluronan Synthase 2 Gene in Transformed Human Keratinocytes and Increases Hyaluronan in Hairless Mouse Skin. Biochemical and Biophysical Research Communications, 316, 348-355. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Lee, H.U., Bae, E.A., Han, M.J., et al. (2005) Hepatoprotective Effect of Ginsenoside Rb1 and Compound K on Tert-Butyl Hydroperoxide-Induced Liver Injury. Liver International, 25, 1069-1073.
[Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
张雷明, 傅风华, 王天, 等. 人参皂苷CK对四氯化碳致大鼠慢性肝损伤的影响[J]. 时珍国医国药, 2006(1): 38-39.
|
|
[8]
|
聂忠富, 孙小燕, 张太平, 等. 人参皂苷Compound K对动脉粥样硬化大鼠氧化应激、炎症因子和血管活性物质的影响[J]. 河北中医, 2019, 41(7): 1042-1047.
|
|
[9]
|
Riveros-McKay, F., Mistry, V., Bounds, R., et al. (2019) Genetic Architecture of Human Thinness Compared to Severe Obesity. PLOS Genetics, 15, e1007603. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Sugden, M.C., Bulmer, K., Gibbons, G.F., et al. (2002) Pe-roxisome-Proliferator-Activated Receptor-Alpha (PPARalpha) Deficiency Leads to Dysregulation of Hepatic Lipid and Carbohydrate Metabolism by Fatty Acids and Insulin. Biochemical Journal, 364, 361-368. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Item, F., Wueest, S., Lemos, V., et al. (2017) Fas Cell Surface Death Receptor Controls Hepatic Lipid Metabolism by Regulating Mitochondrial Function. Nature Communications, 8, Article No. 480.
[Google Scholar] [CrossRef] [PubMed]
|